Top Markets
Coin of the day
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
주식 순위 #28164
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
주가
$0.5495
마지막 동기화: 2025-05-15
시가총액
$28.14M
변동 (1일)
4.70%
변동 (1년)
0.00%
국가
US
거래 Enzo Biochem, Inc. (ENZ)

카테고리

Enzo Biochem, Inc. (ENZ)의 매출
Apr 2025 기준 매출 TTM: $27.48M
Enzo Biochem, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $27.48M입니다. 2023년에 회사는 $31.06M의 수익을 올렸으며 이는 2022년의 $107.07M 대비 감소입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Enzo Biochem, Inc.의 수익 기록 (2000 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $27.48M -13.89%
2024 $31.91M 2.72%
2023 $31.06M -70.99%
2022 $107.07M -9.05%
2021 $117.73M 54.87%
2020 $76.02M -6.34%
2019 $81.17M -22.48%
2018 $104.71M -2.87%
2017 $107.80M 4.90%
2016 $102.77M 5.30%
2015 $97.60M 1.72%
2014 $95.95M 2.39%
2013 $93.71M -9.10%
2012 $103.08M 1.03%
2011 $102.03M 5.10%
2010 $97.08M 8.38%
2009 $89.57M 15.14%
2008 $77.80M 47.04%
2007 $52.91M 32.85%
2006 $39.83M -8.24%
2005 $43.40M 4.22%
2004 $41.64M -21.08%
2003 $52.77M -2.31%
2002 $54.02M -7.52%
2001 $58.41M 16.75%
2000 $50.03M 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
$46.34B 168,547.86%
US
$25.11B 91,281.26%
US
- -
CN
$2.71B 9,752.87%
US
$4.55B 16,472.24%
US